Dalian BIO-CHEM Company Limited
603360.SS · SHH
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | CN¥651,627 | CN¥541,014 | CN¥845,334 | CN¥668,244 |
| Short-Term Investments | CN¥100,000 | CN¥50,000 | CN¥0 | CN¥0 |
| Receivables | CN¥426,573 | CN¥459,260 | CN¥472,927 | CN¥551,582 |
| Inventory | CN¥1,147,718 | CN¥1,129,635 | CN¥937,608 | CN¥902,354 |
| Other Curr. Assets | CN¥57,359 | CN¥57,670 | CN¥50,714 | CN¥36,936 |
| Total Curr. Assets | CN¥2,407,930 | CN¥2,327,705 | CN¥2,651,597 | CN¥2,513,034 |
| Property Plant & Equip (Net) | CN¥673,884 | CN¥679,754 | CN¥705,482 | CN¥696,430 |
| Goodwill | CN¥230,532 | CN¥230,532 | CN¥230,532 | CN¥230,532 |
| Intangibles | CN¥128,391 | CN¥131,320 | CN¥139,703 | CN¥137,206 |
| Long-Term Investments | CN¥150,042 | CN¥146,848 | CN¥0 | CN¥0 |
| Tax Assets | CN¥27,482 | CN¥26,118 | CN¥24,456 | CN¥28,407 |
| Other NC Assets | CN¥37,496 | CN¥37,881 | CN¥157,251 | CN¥34,160 |
| Total NC Assets | CN¥1,247,828 | CN¥1,252,453 | CN¥1,257,424 | CN¥1,126,736 |
| Other Assets | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Total Assets | CN¥3,655,758 | CN¥3,580,158 | CN¥3,909,021 | CN¥3,639,770 |
| Liabilities | – | – | – | – |
| Payables | CN¥93,994 | CN¥86,129 | CN¥130,986 | CN¥117,719 |
| Short-Term Debt | CN¥411,576 | CN¥389,364 | CN¥524,195 | CN¥423,938 |
| Tax Payable | CN¥0 | CN¥24,383 | CN¥22,785 | CN¥49,783 |
| Deferred Revenue | CN¥199,878 | CN¥0 | CN¥0 | CN¥0 |
| Other Curr. Liab. | CN¥62,766 | CN¥341,554 | CN¥275,042 | CN¥446,227 |
| Total Curr. Liab. | CN¥812,169 | CN¥859,909 | CN¥953,008 | CN¥1,112,527 |
| LT Debt | CN¥683,858 | CN¥474,453 | CN¥445,000 | CN¥86,000 |
| Deferred Rev, NC | CN¥12,431 | CN¥12,752 | CN¥11,774 | CN¥8,055 |
| Deferred Tax Liab, NC | CN¥37,222 | CN¥39,322 | CN¥43,537 | CN¥52,896 |
| Other NC Liab. | CN¥6,952 | CN¥7,616 | CN¥8,163 | CN¥6,489 |
| Total NC Liab. | CN¥765,286 | CN¥559,139 | CN¥538,477 | CN¥176,046 |
| Other Liabilities | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Cap. Leases | CN¥0 | CN¥24,996 | CN¥30,004 | CN¥22,605 |
| Total Liabilities | CN¥1,577,455 | CN¥1,419,048 | CN¥1,491,485 | CN¥1,288,573 |
| Equity | – | – | – | – |
| Pref Stock | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Common Stock | CN¥706,224 | CN¥706,224 | CN¥504,445 | CN¥504,445 |
| Retained Earnings | CN¥622,080 | CN¥588,872 | CN¥1,051,691 | CN¥1,001,529 |
| AOCI | CN¥289,506 | CN¥0 | CN¥0 | CN¥0 |
| Other Equity | CN¥0 | CN¥203,091 | CN¥284,931 | CN¥197,624 |
| Total Equity | CN¥1,506,239 | CN¥1,583,063 | CN¥1,841,068 | CN¥1,788,474 |
| Supplemental Information | – | – | – | – |
| Minority Interest | CN¥572,064 | CN¥578,047 | CN¥576,468 | CN¥562,723 |
| Total Liab. & Tot. Equity | CN¥3,655,758 | CN¥3,580,158 | CN¥3,909,021 | CN¥3,639,770 |
| Net Debt | CN¥443,807 | CN¥322,803 | CN¥123,860 | -CN¥158,306 |